The DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents
Open accessAbstract
Global obesity is a pandemic status, estimated to affect over 2 billion people, that has resulted in an enormous strain on healthcare systems worldwide. The situation is compounded by the fact that apart from the direct costs associated with overweight pathology, obesity presents itself with a number of comorbidities, including an increased risk for the development of neurodegenerative disorders. Alzheimer disease (AD), the main cause of senile dementia, is no exception. Spectacular failure of the pharmaceutical industry to come up with effective AD treatment strategies is forcing the broader scientific community to rethink the underlying molecular mechanisms leading to cognitive decline. To this end, the emphasis is once again placed on the experimental animal models of the disease. In the current study, we have focused on the effects of a high-fat diet (HFD) on hippocampal-dependent memory in C57/Bl6 Wild-type (WT) and APPswe/PS1dE9 (APP/PS1) mice, a well-established mouse model of familial AD. Our results indicate that the continuous HFD administration starting at the time of weaning is sufficient to produce β-amyloid-independent, hippocampal-dependent memory deficits measured by a 2-object novel-object recognition test (NOR) in mice as early as 6months of age. Furthermore, the resulting metabolic syndrome appears to have direct effects on brain insulin regulation and mitochondrial function. We have observed pathological changes related to both the proximal and distal insulin signaling pathway in the brains of HFD-fed WT and APP/PS1 mice. These changes are accompanied by a significantly reduced OXPHOS metabolism, suggesting that mitochondria play an important role in hippocampus-dependent memory formation and retention in both the HFD-treated and AD-like rodents at a relatively young age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is also worth noting that insulin resistance leads to a reduced Aβ degradation by IDE, hence promoting the Aβ accumulation (Ho et al., 2004; Zhao et al., 2004; Petrov et al., 2015).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Petrov et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,846
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K., & Brayne, C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70136-x · Cited by 2,466
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period
Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Research works printed but not linked: 1
- Mattson, 1997, Mother’s legacy: mitochondrial DNA mutations and Alzheimer's disease, Trends Neurosci., 20, 373
Cited by
Sorted by citations
Inflammatory Links Between High Fat Diets and Diseases
Duan, Y., Zeng, L., Zheng, C., Song, B., Li, F., Kong, X., & Xu, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02649 · Cited by 495
“Hence, HFD-triggered peripheral hyperinsulinemia to some extent can initially provokes insulin deficiency in the brain, leading to lower expression of insulin degrading enzyme and less degradation (accumulation) of Aβ (96).”
BackgroundMitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
Giorgi, C., Marchi, S., Simões, I. C. M., Ren, Z., Morciano, G., Perrone, M., Patalas‐Krawczyk, P., Borchard, S., Jędrak, P., Pierzynowska, K., et al. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 484
Gubert, C., Kong, G., Renoir, T., & Hannan, A. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104621 · Cited by 387
Wang, Y., Tong, Q., Ma, S.-R., Zhao, Z.-X., Pan, L.-B., Cong, L., Han, P., Peng, R., Yu, H., Lin, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00456-5 · Cited by 319
Therapies for Prevention and Treatment of Alzheimer’s Disease
Mendiola-Precoma, J., Berumen, L. C., Padilla, K., & García‐Alcocer, G. (2016) · BioMed Research International · doi:10.1155/2016/2589276 · Cited by 262
“It was recently reported that a high-fat diet causes damage similar to that observed in Alzheimer’s pathology, such as potentiation of β-secretase processing of APP [73], cognitive impairment [74], and mitochondrial damage associated with insulin resistance [75].”
BackgroundLu, Y., Dong, Y., Tucker, D., Wang, R., Ahmed, M. E., Brann, D. W., & Zhang, Q. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160869 · Cited by 222
Obesity-related cognitive impairment: The role of endothelial dysfunction
Buie, J. N. J., Watson, L. S., Smith, C. J., & Sims‐Robinson, C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104580 · Cited by 138
Fatty acids and their therapeutic potential in neurological disorders
Lei, E., Vacy, K., & Boon, W. C. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.02.014 · Cited by 128
Wakabayashi, T., Yamaguchi, K., Matsui, K., Sano, T., Kubota, T., Hashimoto, T., Mano, A., Yamada, K., Matsuo, Y., Kubota, N., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0315-7 · Cited by 119
“, insulin degrading enzyme (IDE) and neprilysin (NEP) [19, 33, 34].”
BackgroundBanerjee, A., Mukherjee, S., & Maji, B. K. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.04.009 · Cited by 121
Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
Doroszkiewicz, J., Farhan, J. A., Mroczko, J., Winkel, I., Perkowski, M., & Mroczko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115721 · Cited by 108
Yang, L., Wang, Y., Li, Z., Wu, X., Mei, J., & Zheng, G. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120714 · Cited by 106
Busquets, O., Ettcheto, M., Pallàs, M., Beas‐Zárate, C., Verdaguer, E., Auladell, C., Folch, J., & Camins, A. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.11.002 · Cited by 107
Medrano-Jiménez, E., Jiménez-Ferrer, I., Pedraza‐Escalona, M., Ramírez-Serrano, C. E., Álvarez‐Arellano, L., Cortés‐Mendoza, J., Herrera-Ruiz, M. L., Jiménez‐Ferrer, E., Zamilpa, A., Tortoriello, J., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1515-3 · Cited by 100
Calsolaro, V., & Edison, P. (2015) · CNS Drugs · doi:10.1007/s40263-015-0301-8 · Cited by 93
García-Serrano, A. M., & Duarte, J. M. N. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00229 · Cited by 95
Kang, S., Kim, C. H., Jung, H., Kim, E., Song, H., & Lee, J. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.029 · Cited by 92
“, 2010), causes mitochondrial homeostasis deficiency (Petrov et al., 2015), and impairs hippocampus-dependent memory function (McNeilly et al.”
Rollins, C. P. E., Gallino, D., Kong, V., Ayranci, G., Devenyi, G. A., Germann, J., & Chakravarty, M. M. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.11.016 · Cited by 79
Fructose consumption reduces hippocampal synaptic plasticity underlying cognitive performance
Cisternas, P., Salazar, P. L., Serrano, F. G., Montecinos-Oliva, C., Arredondo, S. B., Varela‐Nallar, L., Salesa Barja, Y., Vio, C. P., Gómez‐Pinilla, F., & Inestrosa, N. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.016 · Cited by 85
Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
Akhtar, A., Gupta, S. M., Dwivedi, S., Kumar, D., Shaikh, M. F., & Negi, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c05609 · Cited by 85
From Obesity to Hippocampal Neurodegeneration: Pathogenesis and Non-Pharmacological Interventions
Lee, T. H.-Y., & Yau, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010201 · Cited by 78
Palomera‐Ávalos, V., Griñán‐Ferré, C., Puigoriol‐Illamola, D., Camins, A., Sanfeliu, C., Canudas, A. M., & Pallàs, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9770-0 · Cited by 74
“tance and beta-amyloid and neurofibrillary tangle (NFT) accumulation [10, 11].”
BackgroundPiccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73
“It is also worth noting that insulin resistance leads to a reduced Aβ degradation by IDE, hence promoting the Aβ accumulation (Ho et al., 2004; Zhao et al., 2004; Petrov et al., 2015).”
BackgroundState of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease
Rhea, E. M., Leclerc, M., Yassine, H. N., Capuano, A. W., Tong, H., Petyuk, V. A., Macauley, S. L., Fioramonti, X., Carmichael, O., Calon, F., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0814 · Cited by 70
“In another study, no difference in basal INSRβ activation was observed in the hippocampus of wild-type (WT) or the APP/PS1 mouse model of AD after 6 months of HFD, only a decrease in pAkt(S 473 ), along with, surprisingly, higher relative phosphorylation of other kinases (Table 1) [170].”
BackgroundWang, C., Guo, Y., Zhou, M., Xue, C., Chang, Y., Zhang, T., & Wang, Y. (2019) · Food & Function · doi:10.1039/c8fo01822g · Cited by 69
The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat
Stacpoole, P. W., & McCall, C. E. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.02.007 · Cited by 70
Kim, J. M., Park, C. H., Park, S. K., Seung, T. W., Kang, J. Y., Ha, J. S., Lee, D. S., Lee, U., Kim, D., & Heo, H. J. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00297 · Cited by 68
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
Folch, J., Olloquequi, J., Ettcheto, M., Busquets, O., Sánchez‐López, E., Cano, A. C., Espinosa-Jiménez, T., García, M. L., Beas‐Zárate, C., Casadesús, G., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00236 · Cited by 70
de Matos, A. M., Macedo, M. P., & Rauter, A. P. (2017) · Medicinal Research Reviews · doi:10.1002/med.21440 · Cited by 68
Asadbegi, M., Komaki, A., Salehi, I., Yaghmaei, P., Ebrahim‐Habibi, A., Shahidi, ., Sarihi, A., Asl, S. S., & Golipoor, Z. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.008 · Cited by 64
“, 2014), which has resulted in an enormous strain on healthcare systems (Petrov et al., 2015).”
Bomba, M., Granzotto, A., Castelli, V., ONOFRJ, M. C., Lattanzio, R., Cimini, A., & Sensi, S. L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-190237 · Cited by 65
Diabetes and Alzheimer’s Disease: A Link not as Simple as it Seems
Salas, I. H., & Strooper, B. D. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2690-9 · Cited by 68
“The conclusions from these studies are highly variable depending on the animal model used or the type of diet treatment [71,82,83].”
BackgroundEttcheto, M., Petrov, D., Pedrós, I., Alva, N., Carbonell, T., Beas‐Zárate, C., Pallàs, M., Auladell, C., Folch, J., & Camins, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160150 · Cited by 64
Palomera‐Ávalos, V., Griñán‐Ferré, C., Izquierdo, V., Camins, A., Sanfeliu, C., & Pallàs, M. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1885 · Cited by 63
“8 Diet is an important component of healthy brain aging, and the consumption of a HF diet is known to increase the risk of AD.”
InfluentialBeyond Diabetes: Does Obesity-Induced Oxidative Stress Drive the Aging Process?
Salmon, A. B. (2016) · Antioxidants · doi:10.3390/antiox5030024 · Cited by 62
“For example, several reports have shown high fat diets, or metabolic dysfunction, can accelerate learning and memory loss as well as neurodegeneration in different mouse models of Alzheimer’s disease [107–111].”
Cheng, H., Gang, X., Liu, Y., Wang, G., Zhao, X., & Wang, G. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2019 · Cited by 63
Sághy, É., Sipos, É., Ács, P., Bölcskei, K., Pohóczky, K., Kemény, Á., Zoltán, S., Szőke, É., Sétáló, G., Komoly, S., et al. (2016) · Glia · doi:10.1002/glia.23051 · Cited by 63
“The following antibodies were used at a dilution of 1:1000 unless otherwise stated: anti-myelin-associated glycoprotein (MAG) (Santa Cruz Biotechnology, Santa Cruz, CA), antiphospho-p38 (pThr180/pTyr182) (Sigma-Aldrich, Steinheim, Germany), anti-p44/42 MAPK (ERK1/2), anti-phospho-p44/42 MAPK (pERK1/2) (Thr202/Tyr204),…”
BackgroundMethodHowe, A.-M., Burke, S., O’Reilly, M. E., McGillicuddy, F. C., & Costello, D. A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02756-z · Cited by 61
“Within the CNS, a fat-rich diet is known to induce inflammation [57], facilitate infiltration of immune cells [51, 52] and accelerate the cognitive decline associated with AD [58].”
BackgroundSánchez‐Sarasúa, S., Moustafa, S., García-Avilés, Á., López‐Climent, M. F., Gómez‐Cadenas, ., Olucha-Bordonau, F. E., & Sánchez‐Pérez, A. M. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0137-3 · Cited by 59
“Growing evidence demonstrates that HFD induces insulin resistance, immunological and synaptic alterations in different brain areas [32, 33], and cognitive impairment [34].”
BackgroundSims‐Robinson, C., Bakeman, A., Bruno, E. S., Jackson, S., Glasser, R., Murphy, G. G., & Feldman, E. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163883 · Cited by 58
Lamichhane, G., Liu, J., Lee, S., Lee, D., Zhang, G., & Kim, Y. (2024) · Nutrients · doi:10.3390/nu16020240 · Cited by 56
“Furthermore, disruptions in insulin signaling transduction and mitochondrial dysfunction have been observed in the hippocampus of AD mice [15].”
BackgroundKulas, J. A., Weigel, T. K., & Ferris, H. A. (2020) · Drug Development Research · doi:10.1002/ddr.21643 · Cited by 57
“Numerous studies in rodent models of AD demonstrate that disrupting insulin levels or signaling, through genetic, chemical, or die- tary methods, worsens AD phenotype (Hascup et al., 2019; Petrov et al., 2015; Ramos-Rodriguez et al., 2017; X. Wang et al., 2010).”
BackgroundStudentsova, V., Mora, K. E., Glasner, M. F., Buckley, M. R., & Loiselle, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-27634-4 · Cited by 54
Dohrmann, D. D., Putnik, P., Kovačević, D. B., Simal‐Gándara, J., Lorenzo, J. M., & Barba, F. J. (2018) · Food Research International · doi:10.1016/j.foodres.2018.10.090 · Cited by 52
Sarroca, S., Gatius, A., Rodrı́guez-Farré, E., Vı́lchez, D., Pallàs, M., Griñán‐Ferré, C., Sanfeliu, C., & Corpas, R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108569 · Cited by 52
Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease
Fernández-Martos, C. M., Atkinson, R. A. K., Chuah, M. I., King, A. E., & Vickers, J. C. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.11.002 · Cited by 52
“This predeveloped APP TaqMan assay can detect a region of homology between both human and mouse versions of APP gene [36].”
MethodFouad, G. I. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02996-2 · Cited by 51
Chen, Q., Cao, T., Li, N., Zeng, C., Zhang, S., Wu, X., Zhang, B., & Cai, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667874 · Cited by 50
Wang, C., Shi, H.-H., Xu, J., Yanagita, T., Xue, C., Zhang, T., & Wang, Y. (2020) · Food & Function · doi:10.1039/d0fo01176b · Cited by 49
Salas, I. H., Weerasekera, A., Ahmed, T., Callaerts‐Vegh, Z., Himmelreich, U., D’Hooge, R., Balschun, D., Saido, T. C., Strooper, B. D., & Dotti, C. G. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.001 · Cited by 46
“- Decreased pAKT pathway -Decreased IDE levels/activity (Petrov et al. 2015) APPSwe/PS1dE9 45 kcal % fat Start at 1MO until 6 MO. -Impaired NOR in WT and Tg mice - Increased hippocampal insoluble Aβ42.”
BackgroundWang, W., Yang, J., Xu, J., Yu, H., Liu, Y., Wang, R., Ho, R., Ho, C. S. H., & Pan, F. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.11.015 · Cited by 46
Shepherd, A. L., Tyebji, S., Hannan, A. J., & Burrows, E. L. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0837-1 · Cited by 43
Metabolic determinants of Alzheimer’s disease: A focus on thermoregulation
Tournissac, M., Leclerc, M., Valentin‐Escalera, J., Vandal, M., Bosoi, C. R., Planel, E., & Calon, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101462 · Cited by 41
Kim, J. M., Park, S. K., Guo, T. J., Kang, J. Y., Ha, J. S., Lee, D. S., Lee, U., & Heo, H. J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.013 · Cited by 40
Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance
Al-Sayyar, A., Hammad, M. M., Williams, M. R., Al‐Onaizi, M., Abubaker, J. A., & Alzaïd, F. (2023) · Metabolites · doi:10.3390/metabo13030384 · Cited by 45
Seung, T. W., Park, S. K., Kang, J. Y., Kim, J. M., Park, S. H., Kwon, B. S., Lee, C. J., Kang, J. E., Kim, D., Lee, U., et al. (2017) · Food Research International · doi:10.1016/j.foodres.2017.11.063 · Cited by 39
Adami, P. V. M., Galeano, P., Wallinger, M. L., Quijano, C., Rabossi, A., Pagano, E. S., Olivar, N., Toso, C. R., Cardinali, D. P., Brusco, L. I., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.014 · Cited by 39
Chaney, A. M., Bauer, M., Bochicchio, D., Smigova, A., Kassiou, M., Davies, K. E., Williams, S. R., & Boutin, H. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14251 · Cited by 38
“Cognitive deficits in these tests have been previously reported in both this (Petrov et al. 2015) and other amyloid-based models of AD (Forster et al. 2013; Daniels et al. 2016; Martins et al. 2017), further supporting the link between pathology burden and cognitive decline.”
ResultValentin‐Escalera, J., Leclerc, M., & Calon, F. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230118 · Cited by 37
de Andrade, A. M., Fernandes, M. D. C., de Fraga, L. S., Porawski, M., Giovenardi, M., & Guedes, R. P. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0080-7 · Cited by 39
Maniam, J., Antoniadis, C. P., Youngson, N. A., Sinha, J. K., & Morris, M. J. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00086 · Cited by 35
Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques
Natunen, T., Martiskainen, H., Marttinen, M., Gabbouj, S., Koivisto, H., Kemppainen, S., Kaipainen, S., Takalo, M., Svobodová, H., Leppänen, L., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00415-2 · Cited by 36
“We successfully induced obesity and diabetic phenotype in all of the mouse lines used by applying a sixmonth TWD regime, starting at the age of 7 months, which is in line with previous reports [13, 16, 20, 82].”
BackgroundResultInfluentialRibes‐Navarro, A., Atef, M., Sánchez‐Sarasúa, S., Beltrán-Bretones, M. T., Olucha-Bordonau, F. E., & Sánchez‐Pérez, A. M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1091-z · Cited by 35
Rottscholl, R., Haegele, M., Jainsch, B., Xu, H. W., Respondek, G., Höllerhage, M., Rösler, T. W., Bony, E., Ven, J. L., Guérineau, V., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13835 · Cited by 33
Ettcheto, M., Sánchez‐López, E., Gómez-Mínguez, Y., Cabrera, H., Busquets, O., Beas‐Zárate, C., García, M. L., Carro, E., Casadesús, G., Auladell, C., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0868-4 · Cited by 32
Zuliani, I., Lanzillotta, C., Tramutola, A., Barone, E., Marzia Perluigi, A., Rinaldo, S., Paone, A., Cutruzzolà, F., Bellanti, F., Spinelli, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073746 · Cited by 32
“…Western-style diet [12], thus leading to obesity and T2DM, demonstrated impaired performance in learning and memory tasks, alterations of synaptic integrity, altered CA1-related long-term depression (LTD) and long-term potentiation (LTP), and the development of AD pathological hallmarks [13–16].”
Yang, W., Shen, Z., Wen, S., Wang, W., & Hu, M. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0660-5 · Cited by 32
“[1, 2], but is also closely related to neurodegenerative diseases such as Alzheimer’s disease (AD) [3, 4], Parkinson’s disease [5], and anxiety [6, 7].”
Orexin A attenuates palmitic acid-induced hypothalamic cell death
Duffy, C. M., Nixon, J. P., & Butterick, T. A. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.07.003 · Cited by 31
“Mutations in mitochondrial proteins, impaired mitochondrial dynamics and respiration, and increased ROS production are associated with neurodegenerative diseases such as obesity, Alzheimer's disease, and Parkinson's disease (Cai and Tammineni, 2016; Petrov et al., 2015; Raza et al., 2015; Van Laar and Berman, 2009; Zo…”
BackgroundA metabolic perspective of late onset Alzheimer’s disease
Ettcheto, M., Cano, A. C., Busquets, O., Manzine, P. R., Sánchez‐López, E., Castro-Torres, R. D., Beas‐Zárate, C., Verdaguer, E., García, M. L., Olloquequi, J., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104255 · Cited by 31
Mitochondria in Alzheimer’s Disease and Diabetes-Associated Neurodegeneration: License to Heal!
Cardoso, S., Correia, S. C., Carvalho, C., & Moreira, P. I. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_3 · Cited by 29
Physical exercise consequences on memory in obesity: A systematic review
Sousa, R. A. L. D., Santos, L. G., Lopes, P. M., Cavalcante, B. R. R., Caria, A. C. I., & Cassilhas, R. C. (2021) · Obesity Reviews · doi:10.1111/obr.13298 · Cited by 29
Obesity and neuroinflammatory phenotype in mice lacking endothelial megalin
Bartolomé, F. B., Antequera, D., Tavares, E., Pascual, C., Maldonado, R., Camins, A., & Carro, E. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0800-2 · Cited by 30
“Obesity has been linked to mitochondrial alterations, [14, 15].”
BackgroundRole of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment
Busquets, O., Ettcheto, M., Cano, A. C., Manzine, P. R., Sánchez‐López, E., Espinosa-Jiménez, T., Verdaguer, E., Castro-Torres, R. D., Beas‐Zárate, C., Sureda, F. X., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010255 · Cited by 28
Diabesity and brain disturbances: A metabolic perspective
Cardoso, S., & Moreira, P. I. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.10.002 · Cited by 31
Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats
Gomaa, A. A., Makboul, R. M., El‐Mokhtar, M. A., Abdel‐Rahman, E. A., Ahmed, E. A., & Nicola, M. A. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12585 · Cited by 26
Zameer, S., Alam, M. M., Hussain, S., Vohora, D., Ali, J., Najmi, A. K., & Akhtar, M. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.010 · Cited by 26
Rodriguez‐Perdigon, M., Solas, M., Moreno-Aliaga, M. J., & Ramírez, M. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.004 · Cited by 26
Disruption of leptin signalling in a mouse model of Alzheimer’s disease
King, A. E., Brain, A., Hanson, K., Dittmann, J., Vickers, J. C., & Fernández-Martos, C. M. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0203-9 · Cited by 27
Fanet, H., Tournissac, M., Leclerc, M., Caron, V., Tremblay, C., Vancassel, S., & Calon, F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200637 · Cited by 24
Inoue, Y., Masuda, T., Misumi, Y., Ando, Y., & Ueda, M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136136 · Cited by 25
Hong, S., Nagayach, A., Lü, Y., Peng, H., Duong, Q.-V., Pham, N. B., Vuong, C. A., & Bazan, N. G. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13726 · Cited by 24
Hendrickx, J. O., Martinet, W., Dam, D. V., & Meyer, G. R. Y. D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.651215 · Cited by 28
Animal Models of Alzheimer’s Disease
Newman, M., Kretzschmar, D., Khan, I., Chen, M., Verdile, G., & Lardelli, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00040-1 · Cited by 25
Diabesity and Brain Energy Metabolism: The Case of Alzheimer’s Disease
Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-63260-5_5 · Cited by 24
Guo, Y., Ma, X., Li, P., Dong, S., Huang, X., Ren, X., & Yuan, L. (2020) · Aging · doi:10.18632/aging.202262 · Cited by 21
“We speculate that the HFD-mediated elevation of peripheral insulin might neutralize or counteract the existed selfcompensatory activation of insulin signaling in brain of APP/PS1 mice [39], and ultimately inhibit the activation of insulin receptor and its downstream targets.”
BackgroundHerrero-Labrador, R., Trueba-Sáiz, Á., Martinez‐Rachadell, L., de Sevilla, M. E. F., Zegarra-Valdivia, J. A., Pignatelli, J., Díaz-Pacheco, S., Fernandez, A. M., & Torres‐Alemán, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249675 · Cited by 22
“Further, previous studies using the APP/PS1 mouse model of AD had shown that HFD interferes with central and peripheral insulin signaling [55], which is largely shared by IGF-I.”
Mitochondrial Ultrastructure and Glucose Signaling Pathways Attributed to the Kv1.3 Ion Channel
Kovach, C. P., Al Koborssy, D., Huang, Z., Chelette, B. M., Fadool, J. M., & Fadool, D. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00178 · Cited by 20
“Similar effects of high-fat diet on mitochondrial function have been observed in the central nervous system (Petrov et al., 2015).”
BackgroundWang, Y., Chen, L., Zhao, J., Xia, G., Liu, Z., & Shi, H.-Q. L. W.-M. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c00765 · Cited by 20
Sweet Mitochondria: A Shortcut to Alzheimer’s Disease
Moreira, P. I. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170931 · Cited by 20
Terzo, S., Calvi, P., Nuzzo, D., Picone, P., Allegra, M., Mulè, F., & Amato, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043467 · Cited by 19
Dietary composition affects the development of cognitive deficits in WT and Tg AD model mice
Kadish, I., Kumar, A., Beitnere, U., Jennings, E., McGilberry, W., & van Groen, T. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.003 · Cited by 20
The exposome from neurodevelopment to neurodegeneration: A narrative review
Dallere, S., Rasà, D. M., Pavarino, G., Schellino, R., Vercelli, A., & Boido, M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106247 · Cited by 21
Lee, S., Kim, J. Y., Kim, E., Seo, K. Y., Kang, Y. J., Kim, J. Y., Kim, C. H., Song, H., Saksida, L. M., & Lee, J. E. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.4.277 · Cited by 18
“According to previous studies, HFD increases hippocampal oxidative stress, which reduces NF-E2related factor 2 signaling [24], causes mitochondrial homeostasis deficiency [25], and impairs hippocampus-dependent memory function [26].”
BackgroundBraz, G. R. F., Silva, S. C. D. A., Pedroza, A. A. D. S., de Lemos, M. D. T. B., de Lima, F. A. S., da Silva, A. I., & Lagranha, C. J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173200 · Cited by 18
King, M. R., Anderson, N. J., Deciu, M., Guernsey, L. S., Cundiff, M., Hajizadeh, S., & Jolivalt, C. G. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24706 · Cited by 18
“In addition, Petrov et al (Petrov et al., 2015) showed that phosphorylated tau levels were not increased and alterations in cerebral amyloid levels did not play a critical role in memory loss of APP-PS1 transgenic mice when fed HFD from weaning for 6 months.”
BackgroundMeng, X., Li, D., Kan, R., Xiang, Y., Pan, L., Guo, Y., Yu, P., Luo, P., Zou, H., Huang, L. T., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03183-8 · Cited by 19
“According to previous studies, neuroinflammation and memory impairment occurred in mice fed a HFD for 4–6 months [24, 25] and db/db mice fed a ND for over 6 months [26–28].”
MethodHarris, B. N., Roberts, B. R., DiMarco, G. M., Maldonado, K. A., Okwunwanne, Z., Savonenko, A. V., & Soto, P. L. (2022) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2022.114126 · Cited by 19
Cañeque‐Rufo, H., Sánchez‐Alonso, M. G., Zuccaro, A., Sevillano, J., Ramos, P., & Herradón, G. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113578 · Cited by 14
High-fat diet feeding triggers a regenerative response in the adult zebrafish brain
Azbazdar, Y., Poyraz, Y. K., Özalp, Ö., Nazli, D., Ipekgil, D., Cucun, G., & Özhan, G. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03210-4 · Cited by 15
“In addition to its adverse effects on the liver (Lian et al., 2020), dietary changes including HFD have been associated with brain disorders including dementia, Alzheimer’s disease, and Parkinson’s disease (Morris et al., 2010; Pistell et al., 2010; Petrov et al., 2015; Nuzzo et al., 2018).”
BackgroundPark, S. B., Kang, J. Y., Kim, J. M., Park, S. K., Yoo, S. K., Lee, U., Kim, D., & Heo, H. J. (2019) · Nutrients · doi:10.3390/nu11061319 · Cited by 15
“CNS-IR that is caused by peripheral-IR induces insulin deficiency and hyperglycemia in the brain, resulting in damage to mitochondrial metabolism and neuronal apoptosis, and further causing excessive levels of oxidative stress [7,23,25].”
BackgroundInfluential
Metadata
- Authors
- Petrov, D., Pedrós, I., Artiach, G., Sureda, F. X., Barroso, E., Pallàs, M., Casadesús, G., Beas-Zarate, C., Carro, E., Ferrer, I., Vazquez-Carrera, M., Folch, J., & Camins, A.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Kent State University (US)
- Research Institute Hospital 12 de Octubre (ES)
- Corresponding author
- Camins, Antoni
- ORCID
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 1852
- Issue
- 9
- Pages
- 1687-1699
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W256530927
- Cited by
- 163
- References
- 78
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 15 · 2023: 14 · 2022: 14 · 2021: 19 · 2020: 17 · 2019: 14 · 2018: 24 · 2017: 10 · 2016: 22 · 2015: 3
- FWCI
- 14.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Generalitat de Catalunya (2009/SGR00853)
- Spanish Ministerio de Ciencia e Innovación (SAF2011-23631, SAF2012-39852-C02-01, SAF2012-30708)
- CONACYT (Mexico) (0177594)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- high-fat diet, Alzheimer's disease, hippocampus, insulin signaling, mitochondrial homeostasis, metabolic syndrome, obesity, APP/PS1 mice, novel object recognition, hippocampal-dependent memory, oxidative phosphorylation, neurodegeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review